Il Dong Pharmaceutical Co Ltd (249420) — Cash Flow Quality Index

Latest as of September 2025: 0.50x

Il Dong Pharmaceutical Co Ltd (249420) has a Cash Flow Quality Index of 0.50x as of September 2025. Operating cash flow of ₩11.28 Billion is below net income of ₩22.41 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Il Dong Pharmaceutical Co Ltd (249420) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

0.50x
Operating CF / Net Income

Operating Cash Flow

₩11.28 Billion
KRW

Net Income

₩22.41 Billion
KRW

Data as of

Sep 2025
Most recent filing

Il Dong Pharmaceutical Co Ltd Cash Flow Quality Index (2016–2018)

Historical Cash Flow Quality Index for Il Dong Pharmaceutical Co Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Il Dong Pharmaceutical Co Ltd cash conversion from operations.

Annual Cash Flow Quality Index for Il Dong Pharmaceutical Co Ltd (2016–2018)

Year-by-year earnings quality comparison for Il Dong Pharmaceutical Co Ltd.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2018 5.24x ₩66.65 Billion ₩12.72 Billion ▲ +41.0%
2017 3.72x ₩73.72 Billion ₩19.84 Billion ▲ +1.7%
2016 3.66x ₩45.98 Billion ₩12.58 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.